Interactions between leptin and insulin resistance in patients with prediabetes, with and without NAFLD

被引:28
作者
Bungau, Simona [1 ]
Behl, Tapan [2 ]
Tit, Delia Mirela [1 ]
Banica, Florin [1 ]
Bratu, Ovidiu G. [3 ]
Diaconu, Camelia C. [4 ]
Nistor-Cseppento, Carmen D. [5 ]
Bustea, Cristiana [6 ]
Aron, Raluca A. Corb [6 ]
Vesa, Cosmin Mihai [6 ]
机构
[1] Univ Oradea, Fac Med & Pharm, Dept Pharm, Oradea 410073, Romania
[2] Chitkara Univ, Chitkara Coll Pharm, Rajpura 140401, Punjab, India
[3] Carol Davila Univ Med & Pharm, Clin Dept 3, 8 Eroii Sanitari Blvd, Bucharest 050474, Romania
[4] Carol Davila Univ Med & Pharm, Dept 5, Bucharest 050474, Romania
[5] Univ Oradea, Fac Med & Pharm, Dept Psychoneurosci & Recovery, Oradea 410073, Romania
[6] Univ Oradea, Fac Med & Pharm, Preclin Disciplines, Oradea 410073, Romania
关键词
insulin; leptin; non-alcoholic fatty liver; prediabetes; interactions; FATTY LIVER-DISEASE; INHIBITION; OBESITY;
D O I
10.3892/etm.2020.9327
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
This study explored the link between insulin sensitivity, insulin resistance and leptinaemia in people with prediabetes with and without non-alcoholic fatty liver disease (NAFLD). A total of 143 prediabetes patients were evaluated in the study. Ultrasonography was used for diagnosis of NAFLD, and fasting insulin, postprandial insulin, leptin levels, common clinical/biochemical determinations were determined. In total, 69 (48.25%) of the patients were diagnosed with NAFLD and 74 (51.75%) without NAFLD. Leptin values correlated statistically with fasting insulin in prediabetes patients, while in the patients that were also diagnosed with NAFLD the correlation was stronger. Values of log-leptin <1 ng/ml were found in 64% of patients with prediabetes without NAFLD, and in 2% of patients with prediabetes and NAFLD. In the context of the association between serum leptin levels and a worse biochemical profile in prediabetes patients on one hand, and fatty liver disease and a worse biochemical profile in prediabetes patients on the other, leptin can be considered a possible candidate molecule that mediates the biochemical alterations identified in these patients.
引用
收藏
页数:5
相关论文
共 23 条
  • [1] Adipokines and Non-Alcoholic Fatty Liver Disease: Multiple Interactions
    Adolph, Timon E.
    Grander, Christoph
    Grabherr, Felix
    Tilg, Herbert
    [J]. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2017, 18 (08)
  • [3] The Natural History of Non-Alcoholic Fatty Liver Disease
    Caldwell, Stephen
    Argo, Curtis
    [J]. DIGESTIVE DISEASES, 2010, 28 (01) : 162 - 168
  • [4] Diaconu C, 2019, ROM J MIL MED, V122, P16
  • [5] Enhanced Stat3 Activation in POMC Neurons Provokes Negative Feedback Inhibition of Leptin and Insulin Signaling in Obesity
    Ernst, Marianne B.
    Wunderlich, Claudia M.
    Hess, Simon
    Paehler, Moritz
    Mesaros, Andrea
    Koralov, Sergei B.
    Kleinridders, Andre
    Husch, Andreas
    Muenzberg, Heike
    Hampel, Brigitte
    Alber, Jens
    Kloppenburg, Peter
    Bruening, Jens C.
    Wunderlich, F. Thomas
    [J]. JOURNAL OF NEUROSCIENCE, 2009, 29 (37) : 11582 - 11593
  • [6] The role of leptin in progression of non-alcoholic fatty liver disease
    Ikejima, K
    Okumura, K
    Lang, T
    Honda, H
    Abe, W
    Yamashina, S
    Enomoto, N
    Takei, Y
    Sato, N
    [J]. HEPATOLOGY RESEARCH, 2005, 33 (02) : 151 - 154
  • [7] Dietary Isoliquiritigenin at a Low Dose Ameliorates Insulin Resistance and NAFLD in Diet-Induced Obesity in C57BL/6J Mice
    Lee, Youngmi
    Kwon, Eun-Young
    Choi, Myung-Sook
    [J]. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2018, 19 (10)
  • [8] Obesity, leptin resistance, and the effects of insulin reduction
    Lustig, RH
    Sen, S
    Soberman, JE
    Velasquez-Miejer, PA
    [J]. INTERNATIONAL JOURNAL OF OBESITY, 2004, 28 (10) : 1344 - 1348
  • [9] Leptin: a review of its peripheral actions and interactions
    Margetic, S
    Gazzola, C
    Pegg, GG
    Hill, RA
    [J]. INTERNATIONAL JOURNAL OF OBESITY, 2002, 26 (11) : 1407 - 1433
  • [10] Misra Vijay Laxmi, 2009, Curr Gastroenterol Rep, V11, P50